Scarica l'app Stockscreener
12.06
0.50%
0.06
Precedente Chiudi:
$12.00
Aprire:
$11.98
Volume 24 ore:
199.04K
Relative Volume:
0.36
Capitalizzazione di mercato:
$658.03M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+1.26%
1M Prestazione:
+8.45%
6M Prestazione:
-11.78%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$11.56
$12.12
Intervallo di 1 settimana:
$11.47
$12.19
Portata 52W:
$7.80
$28.09
Bicara Therapeutics Inc Stock (BCAX) Company Profile
Nome
Bicara Therapeutics Inc
Settore
Industria
Telefono
617-468-4219
Indirizzo
116 HUNTINGTON AVENUE SUITE 703, BOSTON
Confronta BCAX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BCAX
Bicara Therapeutics Inc
|
12.06 | 649.30M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Bicara Therapeutics Inc Stock (BCAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-19 | Iniziato | Piper Sandler | Overweight |
| 2025-05-23 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2025-04-17 | Iniziato | Wells Fargo | Underweight |
| 2025-02-06 | Iniziato | Wedbush | Outperform |
| 2024-12-06 | Iniziato | H.C. Wainwright | Buy |
| 2024-11-05 | Iniziato | Rodman & Renshaw | Buy |
| 2024-10-08 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-10-08 | Iniziato | Morgan Stanley | Overweight |
| 2024-10-08 | Iniziato | Stifel | Buy |
| 2024-10-08 | Iniziato | TD Cowen | Buy |
Mostra tutto
Bicara Therapeutics Inc Borsa (BCAX) Ultime notizie
A | Will Bicara Therapeutics Inc. outperform tech stocksEarnings Summary Report & Safe Entry Zone Tips - khodrobank.com
Bicara Therapeutics: A Promising Yet Niche Player in the HNSCC Market - AInvest
Bicara Therapeutics: Promising, But Only For The Patient (NASDAQ:BCAX) - Seeking Alpha
Technical signs of recovery in Bicara Therapeutics Inc.Quarterly Portfolio Report & Low Risk Investment Opportunities - Newser
Will breakout in Bicara Therapeutics Inc. lead to full recoveryMarket Movement Recap & Safe Entry Zone Identification - Newser
Will Bicara Therapeutics Inc. see short term momentumWeekly Profit Analysis & Free High Accuracy Swing Entry Alerts - Newser
What to expect from Bicara Therapeutics Inc. in the next 30 daysWeekly Loss Report & Weekly High Return Forecasts - Newser
Bicara Therapeutics Inc. stock momentum explained2025 Volatility Report & Fast Entry High Yield Tips - Newser
Is Bicara Therapeutics Inc. being accumulated by smart moneyJuly 2025 Review & Risk Managed Trade Strategies - khodrobank.com
Ranking Bicara Therapeutics Inc. among high performing stocks via toolsBuy Signal & Risk Controlled Stock Alerts - Newser
Bicara Therapeutics Inc. stock trend outlook and recovery path2025 Risk Factors & Expert Approved Trade Ideas - Newser
How moving averages guide Bicara Therapeutics Inc. tradingPortfolio Risk Summary & Real-Time Market Trend Scan - Newser
What’s the profit margin of Bicara Therapeutics Inc.July 2025 Institutional & Long-Term Safe Return Strategies - khodrobank.com
Can Bicara Therapeutics Inc. rally from current levelsPortfolio Risk Summary & Risk Adjusted Swing Trade Ideas - Newser
Sentiment analysis tools applied to Bicara Therapeutics Inc.Take Profit & Consistent Growth Equity Picks - Newser
How to escape a deep drawdown in Bicara Therapeutics Inc.Portfolio Gains Summary & Daily Chart Pattern Signals - Newser
Applying Elliott Wave Theory to Bicara Therapeutics Inc.2025 Analyst Calls & Safe Entry Point Alerts - Newser
Published on: 2025-09-03 09:02:39 - Newser
Should I invest in Bicara Therapeutics Inc. before earningsJuly 2025 Weekly Recap & High Return Trade Guides - khodrobank.com
How to track smart money flows in Bicara Therapeutics Inc.Treasury Yields & AI Powered Market Entry Strategies - Newser
Published on: 2025-09-02 14:57:05 - Newser
Advanced analytics toolkit walkthrough for Bicara Therapeutics Inc.2025 Breakouts & Breakdowns & Real-Time Market Sentiment Alerts - Newser
Bicara Therapeutics Inc. stock volume spike explainedWeekly Trade Summary & Weekly High Return Forecasts - Newser
Does Bicara Therapeutics Inc. align with a passive investing strategyMarket Trend Report & Intraday High Probability Alerts - khodrobank.com
Is now a turning point for Bicara Therapeutics Inc.2025 Support & Resistance & Fast Gaining Stock Reports - Newser
What recovery options are there for Bicara Therapeutics Inc.July 2025 Decliners & Fast Gaining Stock Strategy Reports - Newser
How to use Fibonacci retracement on Bicara Therapeutics Inc.Quarterly Profit Report & Weekly High Conviction Ideas - Newser
Income Plays: What’s the profit margin of Bicara Therapeutics Inc.July 2025 News Drivers & Comprehensive Market Scan Reports - khodrobank.com
Can Bicara Therapeutics Inc. outperform under higher oil pricesRate Cut & Weekly Watchlist of Top Performers - khodrobank.com
What’s next for Bicara Therapeutics Inc. stockTrade Analysis Summary & High Win Rate Trade Alerts - khodrobank.com
Institutional scanner results for Bicara Therapeutics Inc.Buy Signal & Weekly Stock Performance Updates - Newser
Can Bicara Therapeutics Inc. sustain earnings growth2025 Sector Review & High Accuracy Swing Entry Alerts - khodrobank.com
Is Bicara Therapeutics Inc. stock overvalued or fairly pricedExit Point & Short-Term Swing Trade Alerts - khodrobank.com
Is it time to cut losses on Bicara Therapeutics Inc.Watch List & Fast Entry Momentum Alerts - Newser
Regression analysis insights on Bicara Therapeutics Inc. performanceBreakout Watch & Daily Stock Trend Watchlist - Newser
Published on: 2025-08-31 15:13:27 - Newser
Visualizing Bicara Therapeutics Inc. stock with heatmapsWeekly Risk Summary & AI Powered Market Trend Analysis - Newser
Is Bicara Therapeutics Inc. stock poised for growthWeekly Gains Report & Low Risk Entry Point Tips - Newser
What’s the recovery path for long term holders of Bicara Therapeutics Inc.Weekly Investment Recap & Reliable Breakout Forecasts - Newser
Will Bicara Therapeutics Inc. price bounce be sustainable2025 Key Lessons & Risk Controlled Stock Alerts - Newser
Bicara Therapeutics Inc Azioni (BCAX) Dati Finanziari
Non sono disponibili dati finanziari per Bicara Therapeutics Inc (BCAX). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Bicara Therapeutics Inc Azioni (BCAX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Meisner Lara | Chief Legal Officer |
Jun 16 '25 |
Sale |
10.43 |
15,829 |
165,096 |
0 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):